| Year |
Citation |
Score |
| 2024 |
Heiss JD, Ray-Chaudhury A, Kleiner DE, Ehrlich DJ, Scott G, Edwards NA, Goldstein DS, Hammoud DA, Hadaczek P, Van Laar VS, Graff SA, Herscovitch P, Lungu C, Hallett M, Lonser RR, et al. Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38718138 DOI: 10.1002/mds.29820 |
0.375 |
|
| 2023 |
Rocco MT, Akhter AS, Ehrlich DJ, Scott GC, Lungu C, Munjal V, Aquino A, Lonser RR, Fiandaca MS, Hallett M, Heiss JD, Bankiewicz KS. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 37098347 DOI: 10.1016/j.ymthe.2023.04.009 |
0.337 |
|
| 2022 |
Lungu C, Nmashie A, George MC, Karp BI, Alter K, Shin S, Tse W, Frucht SJ, Wu T, Koo V, Considine E, Norato G, Hallett M, Simpson DM. Comparison of Ultrasound and Electrical Stimulation Guidance for Onabotulinum Toxin-A Injections: A Randomized Crossover Study. Movement Disorders Clinical Practice. 9: 1055-1061. PMID 36523503 DOI: 10.1002/mdc3.13546 |
0.317 |
|
| 2022 |
Rocco MT, Akhter AS, Ehrlich DJ, Scott GC, Lungu C, Munjal V, Aquino A, Lonser RR, Fiandaca MS, Hallett M, Heiss JD, Bankiewicz KS. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of patients with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35957524 DOI: 10.1016/j.ymthe.2022.08.003 |
0.377 |
|
| 2022 |
Hattori T, Reynolds R, Wiggs E, Horovitz SG, Lungu C, Chen G, Yasuda E, Hallett M. Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson's disease. Neuroimage. Clinical. 35: 103100. PMID 35780660 DOI: 10.1016/j.nicl.2022.103100 |
0.352 |
|
| 2022 |
Vanegas-Arroyave N, Chen DF, Lauro PM, Norato G, Lungu C, Hallett M. Where Do Parkinson's Disease Patients Look while Walking? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34997620 DOI: 10.1002/mds.28917 |
0.698 |
|
| 2021 |
Kilic-Berkmen G, Wright LJ, Perlmutter JS, Comella C, Hallett M, Teller J, Pirio Richardson S, Peterson DA, Cruchaga C, Lungu C, Jinnah HA. The Dystonia Coalition: A Multicenter Network for Clinical and Translational Studies. Frontiers in Neurology. 12: 660909. PMID 33897610 DOI: 10.3389/fneur.2021.660909 |
0.359 |
|
| 2020 |
Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelberg D, ... ... Lungu C, et al. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease. PMID 32508331 DOI: 10.3233/Jpd-202004 |
0.366 |
|
| 2020 |
Lungu C, Ozelius L, Standaert D, Hallett M, Sieber BA, Swanson-Fisher C, Berman BD, Calakos N, Moore JC, Perlmutter JS, Pirio Richardson SE, Saunders-Pullman R, Scheinfeldt L, Sharma N, Sillitoe R, et al. Defining research priorities in dystonia. Neurology. PMID 32098856 DOI: 10.1212/Wnl.0000000000009140 |
0.385 |
|
| 2020 |
Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, ... ... Lungu C, et al. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 11-21. PMID 31914230 DOI: 10.1016/J.Jalz.2019.01.012 |
0.311 |
|
| 2019 |
Park JE, Shamim EA, Panyakaew P, Mathew P, Toro C, Sackett J, Karp B, Lungu C, Alter K, Wu T, Ahmad OF, Villegas M, Auh S, Hallett M. Botulinum toxin and occupational therapy for Writer's Cramp. Toxicon : Official Journal of the International Society On Toxinology. PMID 31351085 DOI: 10.1016/j.toxicon.2019.07.010 |
0.418 |
|
| 2019 |
Heiss JD, Lungu C, Hammoud DA, Herscovitch P, Ehrlich DJ, Argersinger DP, Sinharay S, Scott G, Wu T, Federoff HJ, Zaghloul KA, Hallett M, Lonser RR, Bankiewicz KS. Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31145831 DOI: 10.1002/Mds.27724 |
0.457 |
|
| 2018 |
Srivastava A, Ahmad OF, Pacia CP, Hallett M, Lungu C. The Relationship between Saccades and Locomotion. Journal of Movement Disorders. PMID 30086615 DOI: 10.14802/jmd.18018 |
0.394 |
|
| 2018 |
Ahmad OF, Ghosh P, Stanley C, Karp B, Hallett M, Lungu C, Alter K. Electromyographic and Joint Kinematic Patterns in Runner's Dystonia. Toxins. 10. PMID 29677101 DOI: 10.3390/toxins10040166 |
0.41 |
|
| 2017 |
Jinnah HA, Comella CL, Perlmutter J, Lungu C, Hallett M. Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy? Toxicon : Official Journal of the International Society On Toxinology. PMID 28888929 DOI: 10.1016/J.Toxicon.2017.09.004 |
0.398 |
|
| 2017 |
Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB, Foroud T, German D, Huang X, et al. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomarkers in Medicine. PMID 28644039 DOI: 10.2217/Bmm-2016-0370 |
0.367 |
|
| 2017 |
Pirio Richardson S, Altenmüller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN, Hallett M. Research Priorities in Limb and Task-Specific Dystonias. Frontiers in Neurology. 8: 170. PMID 28515706 DOI: 10.3389/Fneur.2017.00170 |
0.551 |
|
| 2017 |
Tinaz S, Lauro PM, Ghosh P, Lungu C, Horovitz SG. Changes in functional organization and white matter integrity in the connectome in Parkinson's disease. Neuroimage. Clinical. 13: 395-404. PMID 28116232 DOI: 10.1016/J.Nicl.2016.12.019 |
0.688 |
|
| 2017 |
Hattori T, Horovitz S, Reynolds R, Lungu C, Wassermann E, Hallett M. Decreased functional connectivity between striatum and frontal lobe in parkinson’s disease with dementia Journal of the Neurological Sciences. 381: 95. DOI: 10.1016/j.jns.2017.08.312 |
0.304 |
|
| 2016 |
Vanegas N, Zaghloul K, Hallett M, Lungu C. Leg Movements During General Anesthesia. Movement Disorders Clinical Practice. 3: 510-512. PMID 28239614 DOI: 10.1002/mdc3.12310 |
0.435 |
|
| 2016 |
Llaneza Ramos VF, Considine E, Karp BI, Lungu C, Alter K, Hallett M. Ultrasound as Diagnostic Tool for Diaphragmatic Myoclonus. Movement Disorders Clinical Practice. 3: 282-284. PMID 27430001 DOI: 10.1002/mdc3.12295 |
0.36 |
|
| 2016 |
Foki T, Vanbellingen T, Lungu C, Pirker W, Bohlhalter S, Nyffeler T, Kraemmer J, Haubenberger D, Fischmeister FP, Auff E, Hallett M, Beisteiner R. Limb-kinetic apraxia affects activities of daily living in Parkinson's disease: a multi-center study. European Journal of Neurology. PMID 27132653 DOI: 10.1111/Ene.13021 |
0.465 |
|
| 2016 |
Rossi PJ, Gunduz A, Judy J, Wilson L, Machado A, Giordano JJ, Elias WJ, Rossi MA, Butson CL, Fox MD, McIntyre CC, Pouratian N, Swann NC, de Hemptinne C, Gross RE, ... ... Lungu C, et al. Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies. Frontiers in Neuroscience. 10: 119. PMID 27092042 DOI: 10.3389/Fnins.2016.00119 |
0.437 |
|
| 2016 |
Voller B, Lines E, McCrossin G, Tinaz S, Lungu C, Grimes G, Starling J, Potti G, Buchwald P, Haubenberger D, Hallett M. Dose-escalation study of octanoic acid in patients with essential tremor. The Journal of Clinical Investigation. PMID 26927672 DOI: 10.1172/Jci83621 |
0.444 |
|
| 2016 |
Vanegas-Arroyave N, Lauro PM, Huang L, Hallett M, Horovitz SG, Zaghloul KA, Lungu C. Tractography patterns of subthalamic nucleus deep brain stimulation. Brain : a Journal of Neurology. PMID 26921616 DOI: 10.1093/Brain/Aww020 |
0.714 |
|
| 2015 |
Lauro PM, Vanegas-Arroyave N, Huang L, Taylor PA, Zaghloul KA, Lungu C, Saad ZS, Horovitz SG. DBSproc: An open source process for DBS electrode localization and tractographic analysis. Human Brain Mapping. PMID 26523416 DOI: 10.1002/Hbm.23039 |
0.698 |
|
| 2015 |
Park JE, Vanegas-Arroyave N, Hallett M, Lungu C. A Woman With a Novel Mutation of THAP1 With a Prominent Response to Deep Brain Stimulation of the Globus Pallidus Internus. Jama Neurology. 1-2. PMID 26415042 DOI: 10.1001/jamaneurol.2015.1954 |
0.402 |
|
| 2015 |
Ramos VF, Pillai AS, Lungu C, Ostrem J, Starr P, Hallett M. Intraoperative neurophysiology in deep brain surgery for psychogenic dystonia. Annals of Clinical and Translational Neurology. 2: 707-10. PMID 26125045 DOI: 10.1002/Acn3.206 |
0.447 |
|
| 2015 |
Gunduz A, Morita H, Rossi PJ, Allen WL, Alterman RL, Bronte-Stewart H, Butson CR, Charles D, Deckers S, de Hemptinne C, DeLong M, Dougherty D, Ellrich J, Foote KD, Giordano J, ... ... Lungu C, et al. Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline. The International Journal of Neuroscience. 1-11. PMID 25526555 DOI: 10.3109/00207454.2014.999268 |
0.376 |
|
| 2015 |
Karp BI, Ramos VFML, Lungu C, Alter K. 119. Dosing and response to botulinum neurotoxin after deep brain stimulation in generalized dystonia Toxicon. 93. DOI: 10.1016/J.Toxicon.2014.11.122 |
0.3 |
|
| 2014 |
Ramos VF, Karp BI, Lungu C, Alter K, Hallett M. Clinical Response to IncobotulinumtoxinA, after Demonstrated Loss of Clinical Response to OnabotulinumtoxinA and RimabotulininumtoxinB in a Patient with Musician's Dystonia. Movement Disorders Clinical Practice. 1: 383-385. PMID 27066521 DOI: 10.1002/mdc3.12094 |
0.41 |
|
| 2014 |
Lungu C, Malone P, Wu T, Ghosh P, McElroy B, Zaghloul K, Patterson T, Hallett M, Levine Z. Temporal macrodynamics and microdynamics of the postoperative impedance at the tissue-electrode interface in deep brain stimulation patients. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 816-9. PMID 24218525 DOI: 10.1136/Jnnp-2013-306066 |
0.344 |
|
| 2014 |
Voller B, Lines E, McCrossin G, Artiles A, Tinaz S, Lungu C, Hallett M, Haubenberger D. Alcohol challenge and sensitivity to change of the Essential Tremor Rating Assessment Scale. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 555-8. PMID 24123358 DOI: 10.1002/Mds.25667 |
0.369 |
|
| 2013 |
Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, Auh S, Buchwald P, Grimes GJ, Starling J, Potti G, Scheider L, Kalowitz D, Bowen D, Carnie A, et al. Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology. 80: 933-40. PMID 23408867 DOI: 10.1212/Wnl.0B013E3182840C4F |
0.655 |
|
| 2013 |
Lungu C, Considine E, Zahir S, Ponsati B, Arrastia S, Hallett M. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 515-8. PMID 23146065 DOI: 10.1111/ene.12009 |
0.438 |
|
| 2013 |
Alter K, Hallett M, Karp B, Lungu C. Advances in toxin therapy: Utilizing ultrasound guidance for botulinum toxin injections Toxicon. 68: 68-69. DOI: 10.1016/J.TOXICON.2012.07.039 |
0.375 |
|
| 2012 |
Vanbellingen T, Lungu C, Lopez G, Baronti F, Müri R, Hallett M, Bohlhalter S. Short and valid assessment of apraxia in Parkinson's disease. Parkinsonism & Related Disorders. 18: 348-50. PMID 22177625 DOI: 10.1016/j.parkreldis.2011.11.023 |
0.466 |
|
| 2011 |
Lungu C, Karp BI, Alter K, Zolbrod R, Hallett M. Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 750-3. PMID 21506157 DOI: 10.1002/mds.23504 |
0.437 |
|
| 2009 |
Haubenberger D, Nahab F, Toro C, Wittevrongel L, Lungu C, Hallett M, McLane JA. Abstract #4: Therapeutic Effect of 1-Octanol in Essential Tremor Likely Mediated Through Octanoic Acid: Data from a High-Dose Extension Study Neurotherapeutics. 6: 605-605. DOI: 10.1016/J.Nurt.2009.03.005 |
0.651 |
|
| 2009 |
Turk P, Saxby BK, Bardwell M, Edgar C, Wesnes K, Gropman AL, Sailasuta N, Harris K, Ross B, Abulseoud O, Loane DJ, Matsuoka Y, Rebeck GW, Faden AI, Burns MP, ... ... Lungu C, et al. Abstracts from the ASENT 2009 Annual Meeting March 5–7, 2009 Neurotherapeutics. 6: 604-606. DOI: 10.1016/J.Nurt.2009.03.002 |
0.662 |
|
| Show low-probability matches. |